A detailed history of Next Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Next Capital Management LLC holds 16,321 shares of PFE stock, worth $485,549. This represents 0.19% of its overall portfolio holdings.

Number of Shares
16,321
Previous 16,020 1.88%
Holding current value
$485,549
Previous $444,000 2.7%
% of portfolio
0.19%
Previous 0.18%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 20, 2024

BUY
$25.26 - $29.6 $7,603 - $8,909
301 Added 1.88%
16,321 $456,000
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $414,757 - $476,274
16,020 New
16,020 $444,000
Q4 2022

Jan 12, 2023

SELL
$41.75 - $54.5 $10,813 - $14,115
-259 Reduced 2.96%
8,502 $436,000
Q3 2022

Oct 14, 2022

BUY
$43.76 - $53.42 $15,753 - $19,231
360 Added 4.29%
8,761 $383,000
Q2 2022

Jul 20, 2022

BUY
$46.53 - $55.17 $2,745 - $3,255
59 Added 0.71%
8,401 $440,000
Q1 2022

May 02, 2022

BUY
$45.75 - $56.69 $225,456 - $279,368
4,928 Added 144.35%
8,342 $432,000
Q4 2021

Jan 14, 2022

BUY
$41.32 - $61.25 $141,066 - $209,107
3,414 New
3,414 $202,000
Q2 2021

Oct 19, 2021

SELL
$35.91 - $40.68 $237,041 - $268,528
-6,601 Closed
0 $0
Q1 2021

Apr 30, 2021

SELL
$33.49 - $37.77 $185,400 - $209,094
-5,536 Reduced 45.61%
6,601 $239,000
Q4 2020

Jan 27, 2021

BUY
$33.47 - $42.56 $406,225 - $516,550
12,137 New
12,137 $447,000
Q4 2019

Feb 12, 2020

SELL
$32.92 - $37.36 $57,214 - $64,931
-1,738 Closed
0 $0
Q3 2019

Nov 12, 2019

SELL
$32.49 - $42.13 $57,832 - $74,991
-1,780 Reduced 50.6%
1,738 $62,000
Q2 2019

Aug 02, 2019

BUY
$36.98 - $41.52 $120,924 - $135,770
3,270 Added 1318.55%
3,518 $152,000
Q4 2018

Feb 12, 2019

BUY
$38.47 - $43.86 $9,540 - $10,877
248 New
248 $11,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $167B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Next Capital Management LLC Portfolio

Follow Next Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Next Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Next Capital Management LLC with notifications on news.